Managing Skin Aging as a Modifiable Disorder: The Clinical Application of Nourella Dual Approach Comprising a Nano-Encapsulated Retinoid, Retilex-A, and a Skin Proteoglycan Replacement Therapy, Vercilex

The document reviewed the management of skin aging using Nourella®, which combined a nano-encapsulated retinoid, Retilex-A®, and a skin proteoglycan replacement therapy, Vercilex®. The study involved 60 participants and demonstrated that the dual approach significantly improved skin thickness and elasticity compared to a placebo, suggesting its potential effectiveness in managing skin aging. The nano-encapsulation technique enhanced the bioavailability and reduced side effects of Retilex-A®, while Vercilex® improved skin structure and elasticity. The combination therapy was shown to reverse skin aging characteristics, making it a promising option for skin rejuvenation.